Literature DB >> 2546089

MU and delta opioid receptors control differently the horizontal and vertical components of locomotor activity in mice.

A Michael-Titus1, N Dourmap, J Costentin.   

Abstract

The present study investigated the role of mu and delta opioid receptors in the control of the horizontal and vertical components of locomotion. Mice received intracerebroventricularly (i.c.v.) enkephalin analogs specific for either the mu or delta opioid receptors. The administration of the specific mu agonist [D-Ala2-NMePhe4-Gly5(ol)] enkephalin (DAGO) induced a dose-dependent increase in horizontal activity and a decrease in vertical activity. The specific delta agonist [D-Pen2,D-Pen5] enkephalin (DPDPE) increased both components of motor activity. The opiate antagonist naltrexone reversed the effects of DAGO, but did not influence the effects of DPDPE on motor activity. The pretreatment with the delta opiate antagonist ICI 154, 129 completely reversed the effects of DPDPE on locomotion but antagonized only partially the effects of DAGO on locomotion. These results indicate that the two components of locomotor activity--horizontal and vertical activity--are modulated differently by the stimulation of mu or delta opioid receptors.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2546089     DOI: 10.1016/0143-4179(89)90076-0

Source DB:  PubMed          Journal:  Neuropeptides        ISSN: 0143-4179            Impact factor:   3.286


  12 in total

1.  Mu Opioid Receptor Agonist DAMGO Produces Place Conditioning, Abstinence-induced Withdrawal, and Naltrexone-Dependent Locomotor Activation in Planarians.

Authors:  Emily Dziedowiec; Sunil U Nayak; Keenan S Gruver; Tyra Jennings; Christopher S Tallarida; Scott M Rawls
Journal:  Neuroscience       Date:  2018-06-27       Impact factor: 3.590

2.  Bursting activity in myelinated sensory neurons plays a key role in pain behavior induced by localized inflammation of the rat sensory ganglion.

Authors:  W Xie; J A Strong; D Kim; S Shahrestani; J-M Zhang
Journal:  Neuroscience       Date:  2012-01-11       Impact factor: 3.590

3.  Preferential cytoplasmic localization of delta-opioid receptors in rat striatal patches: comparison with plasmalemmal mu-opioid receptors.

Authors:  H Wang; V M Pickel
Journal:  J Neurosci       Date:  2001-05-01       Impact factor: 6.167

4.  Increased rewarding properties of morphine in dopamine-transporter knockout mice.

Authors:  C Spielewoy; F Gonon; C Roubert; V Fauchey; M Jaber; M G Caron; B P Roques; M Hamon; C Betancur; R Maldonado; B Giros
Journal:  Eur J Neurosci       Date:  2000-05       Impact factor: 3.386

5.  Effects of antisense oligonucleotides on brain delta-opioid receptor density and on SNC80-induced locomotor stimulation and colonic transit inhibition in rats.

Authors:  L Negri; M Broccardo; R Lattanzi; P Melchiorri
Journal:  Br J Pharmacol       Date:  1999-12       Impact factor: 8.739

6.  Rats rapidly develop tolerance to the locomotor-inhibiting effects of the novel neuropeptide orphanin FQ.

Authors:  D P Devine; L Taylor; R K Reinscheid; F J Monsma; O Civelli; H Akil
Journal:  Neurochem Res       Date:  1996-11       Impact factor: 3.996

7.  Long-term sensitization to the activation of cerebral delta-opioid receptors by the deltorphin Tyr-D-Ala-Phe-Glu-Val-Val-Gly-NH2 in rats exposed to morphine.

Authors:  P Melchiorri; M Maritati; L Negri; V Erspamer
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

Review 8.  Pharmacological traits of delta opioid receptors: pitfalls or opportunities?

Authors:  Richard M van Rijn; Julia N Defriel; Jennifer L Whistler
Journal:  Psychopharmacology (Berl)       Date:  2013-05-07       Impact factor: 4.530

9.  Targeting pain-depressed behaviors in preclinical assays of pain and analgesia: drug effects on acetic acid-depressed locomotor activity in ICR mice.

Authors:  Glenn W Stevenson; Jim Cormier; Hannah Mercer; Chloe Adams; Catherine Dunbar; S Stevens Negus; Edward J Bilsky
Journal:  Life Sci       Date:  2009-06-24       Impact factor: 5.037

10.  Altered hematopoiesis, behavior, and sexual function in mu opioid receptor-deficient mice.

Authors:  M Tian; H E Broxmeyer; Y Fan; Z Lai; S Zhang; S Aronica; S Cooper; R M Bigsby; R Steinmetz; S J Engle; A Mestek; J D Pollock; M N Lehman; H T Jansen; M Ying; P J Stambrook; J A Tischfield; L Yu
Journal:  J Exp Med       Date:  1997-04-21       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.